Xcout Intel
Alixia, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Alixia, Inc. among biotechnology companies — ranked by similarity to what Alixia, Inc. actually does, not by market-cap band.
Subscribe to see Alixia, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Alixia, Inc.
Alixia, Inc. is a biotechnology company that develops therapeutics targeting tumor ecosystems to address cancer drug resistance and complex, chronic diseases. The company utilizes a research platform integrating biology, biophysics, computational chemistry, and clinical input to discover lead compounds that disrupt metabolic and inflammatory triggers within the tumor microenvironment.
Alixia, Inc. at a glance
Alixia, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $1.8M in July 2024. Xcout tracks 2 named people at Alixia, Inc., including Helen Chen (Co-founder & Co-CEO).
Alixia, Inc. leadership
- Helen ChenCo-founder & Co-CEO
- Olof MollstedtCo-founder & Co-CEO
Alixia, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Alixia, Inc. competitors
Ranked by semantic similarity — how close each company is to Alixia, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Biotech
Alivexis, Inc. is a technology-driven drug discovery enterprise utilizing advanced pharmaceutical platforms with operational foundations in Japan and the United States. Its headquarters is located in Minato-ku, Tokyo, Japan.
Biotech
Axiom Bio is a biotechnology company that develops AI-driven predictive models and translational intelligence tools to assess drug toxicity and minimize clinical trial failures in drug discovery.
Biotech
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotech
Convexia is a biotechnology research company headquartered in San Francisco, California, United States. It utilizes an end-to-end AI stack to quickly find and acquire early-stage drugs, replacing traditional manual diligence processes with fast execution.
Biotechnology / Life Science
Engitix is a biotechnology company that utilizes a proprietary platform based on human Extracellular Matrix (ECM) scaffolds to model and study disease biology. The company develops discovery-stage therapeutics targeting fibrosis, inflammation, and solid tumors, and forms partnerships with pharmaceutical and biotech organizations.
Similar biotechnology company
Centrose LLC is a biotechnology company that develops a next-generation antibody-drug conjugate platform known as Extracellular Drug Conjugates (EDCs). These precision medicines target the cell surfaceome by binding multiple extracellular proteins simultaneously without cell internalization or drug release, aiming to create safer and more potent treatments for cancer and drug-resistant tumors.
Similar biotechnology company
Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Biotech
Earli, Inc. is a U.S. biotechnology company developing synthetic-biology-based technologies for detecting and treating cancer. Its platform is designed to activate signals or therapeutic effects specifically within tumors, serving cancer patients and clinical researchers.
Similar biotechnology company
Lycia Therapeutics, Inc. is a leader in extracellular protein degradation, headquartered in South San Francisco, California.
Similar biotechnology company
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Alixia, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alixia, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →